NIDAN

Nidan Laboratories And Healthcare Share Price

₹28.80 -0.1 (-0.35%)

28 Dec, 2024 01:22

SIP TrendupStart SIP in NIDAN

Start SIP

Performance

  • Low
  • ₹29
  • High
  • ₹29
  • 52 Week Low
  • ₹27
  • 52 Week High
  • ₹41
  • Open Price₹29
  • Previous Close₹29
  • Volume3,000

Investment Returns

  • Over 1 Month -0.86%
  • Over 3 Month -11.38%
  • Over 6 Month -19.44%
  • Over 1 Year -14.67%
SIP Lightning

Smart Investing Starts Here Start SIP with Nidan Laboratories And Healthcare for Steady Growth!

Invest Now

Nidan Laboratories And Healthcare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -
  • PEG Ratio
  • -
  • Market Cap Cr
  • 40
  • P/B Ratio
  • 0.6
  • Average True Range
  • 0.9
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.15
  • RSI
  • 43.62
  • MFI
  • 40.47

Nidan Laboratories And Healthcare Financials

Nidan Laboratories And Healthcare Technicals

EMA & SMA

Current Price
₹28.80
-0.1 (-0.35%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹29.38
  • 50 Day
  • ₹29.99
  • 100 Day
  • ₹30.96
  • 200 Day
  • ₹32.32

Resistance and Support

28.87 Pivot Speed
  • R3 29.13
  • R2 29.07
  • R1 28.93
  • S1 28.73
  • S2 28.67
  • S3 28.53

What's your outlook on Nidan Laboratories And Healthcare?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Nidan Laboratories And Healthcare has an operating revenue of Rs. 98.90 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of -10% needs improvement, ROE of -4% is poor and needs improvement. The company has a reasonable debt to equity of 6%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 20 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C which is evident from recent supply seen, Group Rank of 42 indicates it belongs to a fair industry group of Medical-Services and a Master Score of E is the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nidan Laboratories And Healthcare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-05-23 Audited Results
2023-05-26 Audited Results
2022-11-11 Quarterly Results

Nidan Laboratories And Healthcare F&O

Nidan Laboratories And Healthcare Shareholding Pattern

57.04%
39.6%
3.36%

About Nidan Laboratories And Healthcare

  • NSE Symbol
  • NIDAN
  • BSE Symbol
  • ISIN
  • INE0J6L01013

Similar Stocks to Nidan Laboratories And Healthcare

Nidan Laboratories And Healthcare FAQs

Nidan Laboratories And Healthcare share price is ₹28 As on 28 December, 2024 | 01:08

The Market Cap of Nidan Laboratories And Healthcare is ₹40 Cr As on 28 December, 2024 | 01:08

The P/E ratio of Nidan Laboratories And Healthcare is As on 28 December, 2024 | 01:08

The PB ratio of Nidan Laboratories And Healthcare is 0.6 As on 28 December, 2024 | 01:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23